JAN 02, 2016 03:53 PM PST

HER2-Targeted Vaccine for Breast Cancer

WRITTEN BY: Kara Marker
A vaccine for cancer? The HER2-targeted vaccine could prevent the recurrence of HER2-postive breast cancers by boosting the T cell response to these specific tumor cells.

In a new study from the Perelman School of Medicine at the University of Pennsylvania, scientists noticed that patients whose HER2-positive breast cancer had recurred showed a much weaker T cell response than patients still in remission to HER2 (human epidermal growth factor receptor 2), a gene that is overexpressed and causes uncontrolled cell growth in 25 percent of breast cancers (BreastCancer.org). Their results were published in JAMA Oncology this week.

"The thinking is that the patient's anti-HER2 T cells somehow become exhausted and die or otherwise stop responding," said Brian J. Czerniecki, MD, PhD, and senior author of the study. "We're trying to determine the mechanism, but we already know that we can 'fill the tank' with vaccines to restore that specific responsivity to HER2."

Czerniecki’s “fill the tank” notion comes from revitalizing T cell ability to recruit killer lymphocytes to attack growing tumor cells with stimulatory vaccines. HER2-positive breast cancers are not the only abnormally growing cells to inhibit the immune system in order to evade detection or attack.

To test the ability of immune cells from cancer patients with recurrent HER2-positive breast cancer with the cells of patients still in remission, Czerniecki and his team observed in vivo the T cell response of 95 isolated immune cells when HER2 is injected. Results showed the recurrent cancer patients’ T cells “had only about a tenth of the anti-HER2 responsivity” compared to the T cells of patients whose cancer had not returned.

The team from the University of Pennsylvania is continuing studies on the change in immune response to HER2 over time as well as doing clinical trials with a HER2-targeted vaccine.

To learn more about how HER2 can promote cancer cell growth, watch the following video.
Source: University of Pennsylvania
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 19, 2018
Videos
JUL 19, 2018
Hazmat Spill at Johns Hopkins
Biohazards are a common problem in any kind of scientific research, and if a spill of dangerous materials occurs, it can be deadly. Luckily, a recent spill...
AUG 24, 2018
Cell & Molecular Biology
AUG 24, 2018
Chronic Allergies can Change Cells
Chronic rhinosinusitis is different from allergies; it leads to serious inflammation and swelling in the sinuses that can last for years....
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Combination Therapy for Advanced Melonoma
According to a research study led by UCLA, a bacteria-like agent used in combination with an immunotherapeutic drug may help patients survive longer with a...
OCT 03, 2018
Immunology
OCT 03, 2018
Let's Cut the Brakes on the Immune System
Two laureates receive Nobel Prize for their work regarding immune checkpoint therapy...
OCT 31, 2018
Drug Discovery
OCT 31, 2018
New Drug Target For a Rare Lymphoma
The promise of immunotherapy in oncology is stronger than ever. Now, an international team of scientists and physicians from the Research Institute of the ...
NOV 13, 2018
Immunology
NOV 13, 2018
What Do Heart Disease and Autoimmune Diseases Have in Common?
Researchers at Washington University identify the link between autoimmune diseases and heart disease in mouse model...
Loading Comments...